1 unchanged sentence
Adoption, Modification and Termination of Rule 10b5-1 Plans and Certain Other Trading Arrangements.
−Removed: During the quarter ended March 31, 2026, n o n e of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (as each term is defined in Item 408 of Regulation S-K).
+Added: During the quarter ended June 30, 2026, n o n e of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (as each term is defined in Item 408 of Regulation S-K).
Amended and Restated Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No.
19 unchanged sentences
ACLARIS THERAPEUTICS, INC.
+Added: August 6, 2026
/s/ Neal Walker
1 unchanged sentence
(On behalf of the Registrant)
+Added: August 6, 2026
/s/ Kevin Balthaser
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.